Adams Tracey Morant
Known title: Executive Vice PresidentCIK: 0001739431
Associated companies
Transaction History
| RNST | ▲ Buy | Grant | 2,759 | $0 | 1/1/2023 | View on chart |
| RNST | ▲ Buy | Grant | 2,759 | $0 | 1/1/2023 | View on chart |
| RNST | ▼ Sell | Other | 455 | $0 | 3/24/2022 | View on chart |
| RNST | ▼ Sell | Tax Withholding | 2,243 | $79K | 3/24/2022 | View on chart |
| RNST | ▲ Buy | Grant | 2,653 | $0 | 1/25/2022 | View on chart |
| RNST | ▲ Buy | Grant | 227 | $0 | 1/25/2022 | View on chart |
| RNST | ▲ Buy | Grant | 2,532 | $0 | 1/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Renasant (RNST) Faces Analyst Target Cut and Low-Volatility Warning
Renasant was highlighted in a recent low‑volatility stock list that noted warning signs, suggesting investors should watch for potential risks. The company also scheduled its third‑quarter 2026 webcast and conference call, indicating upcoming earnings discussion. Meanwhile, TD Cowen kept its rating but lowered the price target to $46, reflecting a more modest outlook.
Renasant (RNST) Faces Analyst Target Cut and Low-Volatility Warning. Renasant was highlighted in a recent low‑volatility stock list that noted warning signs, suggesting investors should watch for potential risks. The company also scheduled its third‑quarter 2026 webcast and conference call, indicating upcoming earnings discussion. Meanwhile, TD Cowen kept its rating but lowered the price target to $46, reflecting a more modest outlook.